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I. Introduction 
Since the initial report by Hakomori and Murikami 
[1 ] of an altered glycolipid pattern in polyoma-trans- 
formed baby hamster kidney cells, many investigators 
have demonstrated changes in glycolip!d patterns in 
tumorigenically transformed cells and tissues. Brady 
et al. [2-4] observed accumulation of hematoside 
(GM3)* at the expense of higher gangliosides in sev- 
eral transformed cell lines. This accumulation of GM3 
was subsequently shown to be due to depression i  
activity of the enzyme which transfers N-acetylgalac- 
tosamine from UDP-N-acetylgalactosamine to GM3 
with resultant formation of GM2 [5,6]. Because of 
the inherent difficulties in separating effects of trans- 
formation from cloning and selection effects in cell 
cultures, recent attention has been focused on ganglio- 
side alterations in solid tumors. Siddiqui and Hako- 
mori [7] and Cheema et al. [8] have observed that 
disialogangliosides accumulate at the expense of 
trisialogangliosides in several lines of Morris hepato- 
mas. More recently Keenan and Morr6 [9] found that 
GM1 accumulates in chemically induced rat mammary 
* Standard abbreviations u ed are: GM3, sialylgalactosyl- 
glucosylceramide; GM2, N-acetylgalactosaminyl-(sialyl)- 
galactosylglucosylceramide; GM 1, galactosyl-N-acetylgalacto- 
saminyl-(sialyl)-galactosylglucosylceramide; GD 3, (sialyl)2 
galactosylglucosylceramide; GDla,sialyl-galactosyl-N-acetyl- 
gal actosaminyl-(sialyl)-galactosylglucosylceramide; GDlb, 
galac t osyl-N-acetyl-galactosyl-(sialyl)2 -galactosylgluc osylcer- 
amide; NAN, N-acetylneuraminic acid; Gal, galactose; Glc, 
glucose; UDP, uridine-5'-diphosphate; CMP, cytidine-5'-mono- 
phosphate; GalNAc, N-acetylgalactosamine. Ganglioside ab- 
breviations are those of Svennerholm [24]. 
carcinomas due to depression of the sialyl transferase 
which functions in the conversion of GMI to the GDla 
disialoganglioside. 
Altered glycolipid patterns occurring during malig- 
nant transformation are believed to reflect membrane 
changes which are phenotypic manifestations of tu- 
morigenesis. If these alterations are necessary to per- 
mit malignant growth, they should be of general 
occurence in tumors. To explore this possibility we 
have studied the synthesis and distribution ofganglio- 
sides in a transplantable avian lymphoid tumor. This 
tumor cell line was established in chickens in 1937 
[10] and has been maintained by serial passage. This 
tumor is transplantable but not transmissible 
[11-13], although avirus (RPL12) can be isolated 
from the tumor which produces tumors distant 
to the site of innoculation after a very long incuba- 
tion time [14]. The available vidence indicates that 
bursal ymphocytes are the cells of origin of the 
transplantable lymphoid tumor [ 15, 16]. 
2. Materials and methods 
Rapidly growing transplantable lymphoid tumours 
(TLT) were harvested from 5-weeks old Hubbard 
broiler-type chickens 10 days after inoculation. Tu- 
mors were minced in Rous-Turner saline [13] con- 
taining 10% dimethylsulfoxide, filtered, frozen and 
held at -60°C to provide a common pool of tumor 
cells used to inoculate all birds in this study. Aliquots 
of TLT cell inoculum were thawed and injected 
either intramuscularly in the right pectoral muscle 
or in the abdominal cavity of 4-weeks-old chickens. 
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Table 1 
Composition of avian transplantable lymphoid tumor and control tissues. 
Total Bound Ganglioside Total Lipid 
Tissue sialic acid a sialic acid a sialic acid a lipid b phosphorus c 
Bursa 17.54 16.76 2.34 0.22 3.50 
Thymus 17.59 14.18 1.64 0.80 3.44 
Muscle 8.82 6.23 0.30 0.12 0.89 
IM Tumor 1 23.41 15.68 1.62 0.24 1.52 
IM Tumor 2 18.72 13.93 1.47 0.27 2.64 
IP Tumor 1 25.12 20.37 1.62 0.63 5.29 
IP Tumor 2 38.39 32.88 2.10 0.73 6.34 
aNanomoles per mg protein. 
bMg per mg protein. 
CMicrograms per mg protein. 
The tumors, localized.at the inoculation sites in the 
muscle (designated IM tumors hereafter) or on the 
serosa of the abdominal cavity (designated IP tumors 
hereafter), were harvested 10 days later. Tumors 
were dissected free of normal and necrotic tissue, 
minced and placed in ice-cold 0.32 M sucrose- 14 mM 
2-mercaptoethanol. Bursa of Frabicius, thymus and 
pectoral muscle were removed from control birds 
of the same age and each pooled, minced and placed 
in 0.32 M sucrose-14 mM 2-mercaptoethanol. 
Samples were homogenized [17] and the protein [18] 
and total and bound sialic acid [19] contents were 
determined. Lipids were extracted and gangliosides 
were recovered and measured by sialic acid assay as 
in previous tudies [17, 20]. Total lipid was determined 
gravimetrically and lipid phosphorus by colorimetric 
assay [21 ]. Gangliosides were separated by thin-layer 
chromatography on 500/zm layers of Silica gel G de- 
veloped in chloroform-methanol-28% ammonia-wa- 
ter (60:30:7:3, by volume) and the ganglioside bands 
were detected with resorcinol reagent [22]. 
Total particulate fractions, prepared as in previous 
studies, served as the source of enzyme for glycolipid 
glycosyl transferase assays [9, 23]. These assays were 
performed as described previously [9, 23] .-Specific 
activity values were calculated from the amount of 
radioactive sugar transferred to glycolipid. Glycolipid 
acceptors were prepared as described [9, 23]. Radio- 
active sugar nucleotides were obtained from New 
England Nuclear Corp. Unlabeled sugar nucleotides 
were either commercial preparations or gifts. 
3. Results 
Available evidence indicates that bursal lympho- 
cytes are the cells of origin of lymphoid leucosis tu- 
mor cells [15, 16] and thus bursa was included as a 
control tissue in these studies. It could be speculated 
that thymus may possibly be the origin of  TLT cells 
and for this reason thymus was also assayed. Tumors 
growing in the pectoral muscle (IM tumors) were 
invariably contaminated with muscel to the extent of  
about 15% as determined histologically. Pectoral 
muscle was assayed to assess extent to which muscle 
contamination of IM tumors would affect results. 
Two separate batches of IM and IP tumors were 
analyzed. Each set was obtained from a minimum 
of five birds. For enzyme assays, sets were combined. 
Both IP tumors had higher levels of total and 
bound sialic acids than did IM tumors, bursa and 
thymus (table 1). IM tumors were similar to bursa 
and thymus in levels of total and bound sialic acid. 
No major differences in levels of ganglioside sialic 
acid were evident among the IM and IP tumors, bur- 
sa and thymus. Muscle contained less than half the 
levels of total and bound sialic acids encountered 
in other tissues (table I). Only very low levels of 
ganglioside sialic acid were found in muscle. On a 
protein basis, total lipid content of IM tumors was 
nearly identical to total lipid levels in bursa. Bursa 
contained higher levels of phospholipid than did IM 
tumors (table 1). IP tumors contained nearly 3 times 
more lipid than IM tumors. IP tumors were similar 
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Fig. 1. Thin-layer chromatographic pattern of ganglioside fractions from avian transplantable lymphoid tumor and control tissues. 
1, Bursa; 2, thymus; 3, intramuscular tumor-I;4, intramuscular tumor-2; 5, intraperitoneal tumor-1 6, intraperitoneal tumor-2; 
7, reference gangiiosides GM3 (A), GM2 (B), and GM1 (C). Single arrows denote position of GM 1. Double arrows denote region 
of trisialogangliosides. Approximately 80 nmoles of ganglioside sialic a id from each tissue was applied to the plate. The 250 #m 
silica gel G plate was developed in chloroform-methanol-28% ammonia-water (60:35:7:3, by volume) and was sprayed with 
resoreinol reagent. 
to thymus in total lipid levels. Phospholipids repre- 
sented a higher proportion of total lipids in IP tumors 
than in any of the other tissues examined. As with 
sialic acids, muscle contained much lower levels of 
total lipid and lipid phosphorus than the other tis- 
sues. 
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While there were no appreciable differences in 
total ganglioside l vels in bursa, thymus and the 
tumors, pronounced ifferences were evident in 
ganglioside distribution patterns (fig. 1). Bursa con- 
tained gangliosides migrating with hematosides (GM3), 
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Table 2 
Ganglioside biosynthetic enzyme activities inavian transplantable lymphoid tumor and control tissues. 
Nucleotide Specific activity a 
Acceptor sugar Bursa Thymus Muscle IM Tumor IP Tumor 
Glucosyl ceramide UDP-Gal 110.7 31.9 10.1 63.8 75.5 
None UDP-Gal 16.8 1.7 13.4 11.7 18.5 
Lactosyl ceramide CMP-NAN 147.5 302.8 4.9 40.3 75.7 
GM3 CMP-NAN 41.3 78.6 9.9 14.7 22.6 
GM 1 CMP-NAN 198.6 115.0 6.9 33.5 54.1 
None CMP-NAN 19.6 54.1 6.9 7.8 24.6 
GM3 UDP-GalNAc 306.7 329.2 8.3 240.0 194.2 
None UDP-GalNAc 15.8 8.3 0.8 14.2 18.3 
GM2 UDP-Gal 472.1 192.6 6.3 36.6 57.9 
None UDP-Gal 16.3 18.9 3.8 8.8 13.9 
aSpecific activities are pmoles/mg protein/hr except for UDP-GalNAe transferase where specific activities are CPM/mg protein/hr. 
Reaction mixtures contained 0.4 mg particulate protein., 0.05 t~mole acceptor and 0.05 tzmole nucleotide sugar (0.01 ~mole for 
UDP-GalNAc). Other constituents of the reaction mixtures are given in references [9] and [23]. 
GM2, GM 1, disialogangliosides and trisialogangliosides. 
Particularly evident was the high relative amount of 
a component with GM2 mobility. All of these ganglio- 
sides were also present in thymus. The main difference 
between thymus and bursa was the lower level of the 
ganglioside with GM2 mobility in the former, These 
patterns are in distinct contrast tO those obtained with 
the tumors. Hematosides and bands corresponding to 
disialogangliosides were present in IM and IP tumors 
(fig. 1). A component corresponding to GM2 was also 
present in tumors but in much lower amounts relative 
to bursa and thymus. Tumors were also characterized by
the almost complete absence of gangliosides with GM 1 
and trisialoganglioside mobilities. Thus the major differ- 
ences between control tissues and the tumors were the 
accumulation of disialogangliosides (GD 1 a, GD 1 b and/ 
or GD3) and diminutions of GM2, GM 1 and trisialo- 
gangliosides in tumors. Ganglioside patterns in the 
4 tumors examined were virtually identical. 
Enzymatic activities for several of the glycosyl 
transferases involved in ganglioside biosynthesis are 
given in table 2. Only very low activities of all enzymes 
assayed were encountered in muscle. Thus, these data 
indicate that muscle contamination f IM tumors had 
a neglible effect on the results obtained. 
Among the other tissues examined-bursa, thymus, 
IM and IP tumors-there were differences in activities 
of many of these glycosyl transferases between ormal 
and tumor tissue (table 2). The enzyme UDP-galactose: 
glucosyl ceramide galactosyl transferase (lactosyl cera- 
mide is the product) was most active in bursa and least 
active in thymus. IM and IP tumors had 55 and 61% of 
the activity of bursa with exogenous acceptor. 
Both bursa and thymus had enzymes which trans. 
ferred N-acetyl-neuraminic acid from CMP-N-acetyl- 
neuraminic acid to glycolipid acceptors. Lactosyl cera- 
mide (product = GM3) and GM 1 (product = GDla) 
were more active acceptors than was GM3 (product = 
GD3) in both tissues. Lower levels of these sialyl trans- 
ferases were present in IM and IP tumors with all 
acceptors. The activities in tumors amounted to from 
15-40% of the activities in bursa with exogenous 
acceptors. 
UDP-N-acetylgalactosamine: GM3N-acetylgalac- 
tosamine transferase (product = GM2) was active in 
all tissues. The level of activity in tumors was approx. 
60-80% of the levels in bursa. UDP-N-acetyl-glucosa- 
mine was inactive as a sugar donor with all tissues, in- 
dicating that gangliosides in these tissues contain 
galactosamine and not glucosamine. 
The most pronounced diminution in enzyme activ- 
ity in tumors was in levels of UDP-galactose:GM2 
galactosyl transferase (GM1 is the product). Specific 
activities of this enzyme in IM and IP tumors were 
only approx. 6-10% of the level of activity in bursa. 
To determine whether this diminution in product .
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accumulation was due to the presence of an inhibitor 
or a glycosidase in tumors, mixing experiments were 
conducted. When equal quantities of  bursa and IM or 
IP tumor total particulates were combined, specific 
activities were identical to those calculated for the 
individual enzyme sources. This indicates that the 
low activities in this transferase in tumors is the result 
of lower levels of the galactosyl transferase. 
4. Discussion 
Compared to the control bursal tissue, TLT tumors 
show no changes of great magnitude in total, bound 
and ganglioside sialic acid levels. As with mammalian 
tumors, there are distinct differences in the ganglioside 
pattern of TLT tumors compared to controls. The 
pattern changes observed in TLT tumors differs from 
those changes observed with other neoplastic ells and 
tissues [2-4,  7 -9] .  The general finding has been a 
build-up of one particular ganglioside and the absence 
of any higher ganglioside homologs. This is the expected 
result in view of the stepwise mode of assembly of the 
carbohydrate chain of gangliosides [25] and the finding 
of depression in enzyme activity at the step following 
the ganglioside build-up [5, 6, 9]. 
TLT tumors are characterized by the absence of 
trisialogangliosides as can be seen in fig. I. In addition, 
GM2 is also diminished in amount and GM 1 is almost 
completely absent. The net effect is that GM3 and 
disiaolgangliosides accumulate. The absence of trisialo- 
gangliosides can be explained by the generalized re- 
duction in sialyl transferases observed in tumors. The 
accumulation of disialogangliosides is not easily ex- 
plained since GM3 and GM1 were less active accep- 
tots in tumors compared to controls. The accumula- 
tion of disialogangliosides may be due to an enzymat- 
ic block in conversion of di- to trisialoganglioside. 
The reduced amount of GM2 is difficult to recon- 
cile with the relatively high levels of N-acetylgalacto- 
saminyl transferase encountered in tumors. A partial 
explanation could be the reduced enzyme activities 
at two steps prior to the formation of GM2: the con- 
version of glucosyl ceramide to lactosyl ceramide and 
then to GM3 (which in turn is converted to GM2). The 
virtual absence of GM1 appears to be due to the marked- 
ly lower levels of UDP-galactose:GM2 galactosyl trans- 
gerase in tumors. 
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